128 related articles for article (PubMed ID: 10203542)
1. Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991.
Lozano-Chiu M; Nelson PW; Paetznick VL; Rex JH
J Clin Microbiol; 1999 May; 37(5):1625-7. PubMed ID: 10203542
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.
Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
J Clin Microbiol; 2001 Dec; 39(12):4387-9. PubMed ID: 11724849
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
Espinel-Ingroff A; Canton E; Gibbs D; Wang A
J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species.
Barchiesi F; Schimizzi AM; Fothergill AW; Scalise G; Rinaldi MG
Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):302-4. PubMed ID: 10385023
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
Espinel-Ingroff A
J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
[TBL] [Abstract][Full Text] [Related]
6. Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2004 Jul; 42(7):3117-9. PubMed ID: 15243069
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.
Krishnarao TV; Galgiani JN
Antimicrob Agents Chemother; 1997 Sep; 41(9):1957-60. PubMed ID: 9303393
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.
Chryssanthou E; Cuenca-Estrella M
J Clin Microbiol; 2002 Oct; 40(10):3841-4. PubMed ID: 12354895
[TBL] [Abstract][Full Text] [Related]
9. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Holliday N; Killian SB
J Clin Microbiol; 2004 Feb; 42(2):718-21. PubMed ID: 14766842
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
11. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
Espinel-Ingroff A
J Clin Microbiol; 1998 Oct; 36(10):2950-6. PubMed ID: 9738049
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
Pfaller MA; Diekema DJ; Messer SA; Hollis RJ; Jones RN
Antimicrob Agents Chemother; 2003 Mar; 47(3):1068-71. PubMed ID: 12604543
[TBL] [Abstract][Full Text] [Related]
13. New methods to assess susceptibilities of Aspergillus isolates to caspofungin.
Imhof A; Balajee SA; Marr KA
J Clin Microbiol; 2003 Dec; 41(12):5683-8. PubMed ID: 14662961
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry susceptibility testing for the antifungal caspofungin.
Mitchell M; Hudspeth M; Wright A
J Clin Microbiol; 2005 Jun; 43(6):2586-9. PubMed ID: 15956368
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Pfaller MA; Messer SA; Gee S; Joly S; Pujol C; Sullivan DJ; Coleman DC; Soll DR
J Clin Microbiol; 1999 Mar; 37(3):870-2. PubMed ID: 9986880
[TBL] [Abstract][Full Text] [Related]
16. Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study.
Cantón E; Pemán J; Gobernado M; Alvarez E; Baquero F; Cisterna R; Gil J; Martín-Mazuelos E; Rubio C; Sánchez-Sousa A; Serrano C
Antimicrob Agents Chemother; 2005 Apr; 49(4):1604-7. PubMed ID: 15793151
[TBL] [Abstract][Full Text] [Related]
17. Caspofungin disk diffusion breakpoints and quality control.
Brown SD; Traczewski MM
J Clin Microbiol; 2008 Jun; 46(6):1927-9. PubMed ID: 18400918
[TBL] [Abstract][Full Text] [Related]
18. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus.
Bartizal C; Odds FC
Antimicrob Agents Chemother; 2003 Jul; 47(7):2100-7. PubMed ID: 12821453
[TBL] [Abstract][Full Text] [Related]
19. Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafungin.
Odabasi Z; Paetznick V; Goldstein BP; Rex JH; Ostrosky-Zeichner L
Antimicrob Agents Chemother; 2003 Sep; 47(9):3018-20. PubMed ID: 12937018
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
